MUCUS RELIEF - DM MAXIMUM STRENGTH
NDC 73581-406, Guaifenesin, Dextromethorphan HBr, tablet, from YYBA CORP.
- Product NDC
- 73581-406
- Status
- Listed
- Labeler
- YYBA CORP
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- ANDA
- Application
- ANDA206941
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73581-406 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE60 mg/1
- GUAIFENESIN1200 mg/1
Pharmacologic classes
Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73581-406-01 | 73581040601 | 2 BOTTLE in 1 CARTON (73581-406-01) / 50 TABLET in 1 BOTTLE (73581-406-05) |
| 73581-406-05 | 73581040605 | 50 TABLET in 1 BOTTLE (73581-406-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 73581-406 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73581-406 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73581-406. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.